Jeff Aronin: Entrepreneurial Biotech Executive
Jeff Aronin has more than 20 years of experience developing global biotech and healthcare innovation companies. His expertise in complex science and patient-focused drug development has made him one of the most successful, innovative leaders in the bioscience sector, addressing unmet needs for patients suffering from rare diseases. Jeff’s work as an entrepreneur and scientific visionary have contributed to the development and approval of more than a dozen new medicines and technologies and has created thousands of jobs (Gazetteday).
For the past 10 years, Jeff has served as chairman and chief executive officer of Paragon Biosciences, whose mission is to build innovative biotechnology companies that focus on developing important medicines for patients.
He has also served as chairman of several life science companies, including Paragon Pharmaceuticals, Castle Creek Pharmaceuticals, and Harmony Biosciences. Previously, Jeff was president and chief executive officer of Ovation Pharmaceuticals Inc., a biopharmaceutical company he founded in 2000 that was ultimately acquired by Lundbeck, Inc. in 2009. He served as president and chief executive officer of Lundbeck, Inc. during its acquisition and integration of Ovation Pharmaceuticals.
Jeff is on the corporate boards of Discover Financial Services, Castle Creek Pharmaceuticals and Harmony Biosciences. He is the founder and co-chairman of MATTER, a biotech incubator in Chicago, served as a director of the Economic Club of Chicago, and is on the executive committee of World Business Chicago appointed by Mayor Rahm Emanuel. Aronin is a Crown Fellow at the Aspen Institute and a member of the Commercial Club. He lectures regularly at the University of Chicago Booth School of Business and at Northwestern University Kellogg School of Business.